XM does not provide services to residents of the United States of America.
T
T

Tenaris

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Tenaris CEO sees potential upside in 2025 profit margins

BRIEF-Tenaris CEO sees potential upside in 2025 profit margins Sept 24 (Reuters) - Tenaris TENR.MI CEO and Chairman Paolo Rocca says at a company investor day: BOTTOM LINE IN H2 TO BE IN THE RANGE OF 15% BELOW THE PREVIOUS SEMESTER WE EXPECT FLOOR OF OUR VOLUME PERFORMANCE IN H2 TO BE AROUND 10% BELOW H1 THINK 2024 PROFIT MARGIN WILL BE IN THE MIDD
T

Italy - Factors to watch on September 24

Italy - Factors to watch on September 24 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . ECONOMY Italy's economic growth last year was weaker than previously estimated, national statistics bureau ISTAT reported on Monday, but more positively for the government, the budget deficit and public debt as
C
E
L
T
U
P
I
U

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Sept 20 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 24-Sep-2024 11:00 TENR.MI Tenaris SA Tenaris SA Investor Presentation- London 24-Sep-2024 BMO SMIN.L Smiths Group PLC Full Year 2024 Smiths Group PLC Earnings Release 25-Sep-2024 16:18 EXOR.AS Exor NV Half Year 2024 Exor NV Earnings Release 25-Sep-2024 NTS LPPP.WA L
J
T
H

Draegerwerk, Hikma, Novartis

EUROPE RESEARCH ROUNDUP-Draegerwerk, Hikma, Novartis Sept 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Draegerwerk, Hikma and Novartis, on Tuesday. HIGHLIGHTS * Draegerwerk DRWG.DE : Jefferies raises to hold from underperform * Hikma HIK.L : Berenberg raises to buy from hold * Munters Group AB MTRS.ST : Jefferies raises to buy from hold * Novartis AG NOVN.S : Jefferies cuts to hold from buy * Swedencare AB (Publ) SECARE.ST : J
A
A
A
B
B
B
C
D
G
H
H
N
S
T
U
A
P

Senators want Biden to lower South Korean import quota for piping products

UPDATE 2-Senators want Biden to lower South Korean import quota for piping products Adds Commerce Department, company, industry reaction in paragraphs 3-4 and 7 By David Shepardson WASHINGTON, Aug 30 (Reuters) - Three Democratic U.S. senators urged the Biden administration on Friday to reduce the import quota on oil and gas drilling pipes from South Korea, saying it has affected companies with operations in Ohio and Pennsylvania.
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.